Bacterial conjunctivitis is an inflammation of the eye’s external surface and the inner portion of the eyelid. Redness, swelling, and wet eyes are all indications of bacterial conjunctivitis. Chlamydia trachomatis, Staphylococci, streptococci, and Hemophilus are among the bacteria that cause conjunctivitis. Bacterial conjunctivitis is more common in children and the elderly population, but still, it affects people of all ages. The rising number of cases of bacterial conjunctivitis demands effective medication, which fuels the global bacterial conjunctivitis drugs market growth over the forecast period. Bacterial conjunctivitis spreads due to inadequate hygiene, compromised immune systems, ocular illnesses such as blepharitis and dry eye, and infected cosmetics. It can be avoided by practicing good hygiene, and handwashing minimizes the risk of bacterial conjunctivitis.
To Get a Free Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/714
Bacterial Conjunctivitis Drug Market Taxonomy
By Disease Type;
- Acute Bacterial Conjunctivitis
- Chronic Bacterial Conjunctivitis
By Treatment Type;
- Fluoroquinolones
- Macrolides
- Aminoglycosides
By Route of Administration;
- Topical
- Oral
- Intravitreal
By End User;
- Hospitals
- Clinics
To get Covid-19 Impact PDF Brouchure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/714
The rising prevalence of bacterial conjunctivitis and the availability of generic drugs are propelling the global bacterial conjunctivitis drug market growth over the forecast period
The growth of ophthalmic bacterial infection boosted the demand for antibacterial medications for treating it. According to the National Center for Biotechnology Information (NCBI) 2013 estimate, conjunctivitis impacted around 6 million persons in the U.S. Bacterial conjunctivitis takes about a week to cure, and fluoroquinolones are the most commonly used antibiotics for treating bacterial conjunctivitis. Some drugs in the market are patented, and their patents are due to expire; this is expected to boost the market for less expensive generic drugs. Some of the most successful patented medications, such as zymaxid, moxeza, besivance, and vigamox, are going to expire. After their patents expire, certain drugs end up losing their exclusivity, increasing the usage of generic drugs. The emergence of multi-drug resistance types is expected to drive the global bacterial conjunctivitis drugs market growth over the forecast period. Unnecessary antibiotic use leads disease-causing bacteria to chemically develop and grow resistant to drugs. This may result in the prescribing of strong drugs such as corticosteroids and antibiotics at high doses.
The increasing prevalence of bacterial conjunctivitis necessitates the development of new medications, such as vancomycin ophthalmic ointment, which are in the clinical testing pipeline and a few are awaiting approval. Some of the key issues confronting the bacterial conjunctivitis drug market are patent expiration and public awareness of the disease’s ability to cure itself in a week. Moreover, the change in preference to herbal treatment over pharmacological therapies is expected to create new prospects in the global bacterial conjunctivitis drug market. Furthermore, herbal formulation-based drugs are generally accepted, enabling the development and investments in herbal products for the treating of bacterial conjunctivitis. The aforementioned scenario is expected to drive the global bacterial conjunctivitis drugs market growth during the forecast period.
Geographically, the global bacterial conjunctivitis drug market is divided into Africa, North America, the Middle East, Latin America, The Asia Pacific, and Europe. North America accounts for the largest share in the global bacterial conjunctivitis drugs market, owing to its modern medical facilities and reimbursement regulations. Europe is the second-largest region in the global bacterial conjunctivitis drugs market, trailed by the Asia Pacific region. Due to excessive general awareness of the disease and high per capita income, Asia Pacific is expected to grow significantly during the forecast period.
Major players operating in the global bacterial conjunctivitis drug market growth include Perrigo Company Plc, Bayer Healthcare, Allergan Plc, Novartis AG, Santen Pharmaceutical Co. Ltd., F. Hoffmann-La Roche, Akorn Inc., Pfizer Inc., and Valeant Pharmaceutical International Inc. Companies use numerous techniques to increase their market share, such as mergers and acquisitions. For instance, Shire acquired Foresight Biotherapeutics in 2015 to expand its ophthalmic product portfolio.
To Direct Purchase of this Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/714
Table of Contents:
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations - Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM) - Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis - Global Bacterial Conjunctivitis Drug Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bacterial Conjunctivitis Drug Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bacterial Conjunctivitis Drug Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million) - Global Bacterial Conjunctivitis Drug Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837